Shanghai Haoyuan Chemexpress Co. Ltd. A
医疗健康 · 专科与仿制药
Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
MARKET 市值 17.57B CNY PE 71.7x
52W ¥51.79 – ¥99.8
EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG — 营收 YoY 20.2%
▲ ROE 7.5% 营业利润率 19.3% 净利润率 8.2%
ANALYST 股息率 0.26%